Rottendorf Pharma Selects ValGenesis VLMS After A Comprehensive Review Of Digital Validation Solutions

ValGenesis, Inc., the market leader in enterprise validation lifecycle management systems (VLMS), announced today that Rottendorf Pharma, a prominent contract development and manufacturing organization (CDMO) based in Germany, has chosen ValGenesis VLMS to digitize its corporate validation process.

With more than 95 years of experience, Rottendorf Pharma specializes in developing, manufacturing and packaging formulations and analytical methods for oral solid dosage forms within the pharmaceutical industry. Their services cater to both pharmaceutical and biotechnology companies worldwide. The company is fully foundation-owned with a long-term orientation partnership approach which creates a significant advantage for customers.

Rottendorf Pharma chose ValGenesis VLMS because of its capability to streamline and standardize processes coupled with the intuitive user interface of VLMS 5.0. Moreover, ValGenesis’ cost-effectiveness and the responsiveness of their team solidified their decision. Ultimately, Rottendorf Pharma saw ValGenesis VLMS as an innovative, technologically advanced solution with a clear roadmap for future enhancements.

"As a crucial player in Germany's pharmaceutical supply chain, Rottendorf Pharma is poised for a manufacturing transformation with ValGenesis VLMS," says Steve Reynolds, Chief Revenue Officer at ValGenesis. "Their selection of our digital validation platform aligns perfectly with their commitment to both quality and rapid drug delivery. This partnership exemplifies ValGenesis' dedication to supporting the advanced needs of the CDMO industry.”

“After a thorough comparison of two software providers, we chose ValGenesis VLMS because it aligns perfectly with our needs, offering the specific functions and tools required to streamline and digitize our processes. The software's advanced technology and clear roadmap for future innovation ensure that it will continue to deliver value and support our growth,” says Markus Krellmann, Head of QA Data Quality Compliance at Rottendorf Pharma.